20.301.12% ( -0.23 )
Delay Trading: Nov 16, 09:49:54Financials
Q3 2026 Earnings
Financial report interval: 2026.06.30 - 2026.09.30
Overview: Hezong Medicine Easy-To-Buy Pharmaceutical(300937) the Revenue is 1.03 B (-5.06%);the EBIT is 5.502 M (-2.2%);the EPS is -0.135 (-1500%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
1.03B5.06%
----
----
EBIT
0.01B2.20%
----
----
EPS
-0.13471500.49%
----
----
Upcoming earnings report - FY2026 Annual Earning Release
Available dateApr 16, 2027
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: CNY
Quarterly
EBIT
ActualEstimateUnit: CNY
Quarterly
Net income
ActualEstimateUnit: CNY
Quarterly
EPS
ActualEstimateUnit: CNY
Quarterly
